Target intelligence / Profile preview

Myocardial cell metabolism

01

Overview

Myocardial cell metabolism comprises the network of metabolic pathways and regulatory nodes in cardiac myocytes responsible for generating and using energy substrates, including fatty acids, glucose, ketones, and amino acids[2][7][6]. Dysregulation of these pathways contributes to cardiac diseases such as heart failure and ischemic injury, and multiple enzymes, transporters (e.g., CD36), and signaling molecules within these pathways are recognized as therapeutic targets[1][2][3]. Pharmacological strategies aim to optimize substrate utilization, protect mitochondrial function, reduce oxidative stress, and enhance energy efficiency during pathological states[2][6]. However, "myocardial cell metabolism" as a phrase describes an ensemble of processes rather than a discrete molecular target and should not be used as a canonical drug target or receptor entry[1][2].

Other names
cardiac metabolismmyocardial metabolism
02

Mechanism of action

Inhibition of fatty acid oxidation (increases glucose utilization) Activation of pyruvate dehydrogenase (promotes glucose oxidation) Stimulation of ketone metabolism (increases energy efficiency) O-GlcNAcylation modulation (improves cell survival under stress) Inhibition of mitochondrial succinate metabolism (reduces reperfusion injury) Mitochondrial ROS scavenging (reduces oxidative damage)

03

Biological functions

ATP productionSubstrate utilization (fatty acid oxidation, glucose oxidation, ketone metabolism)HomeostasisResponse to ischemiaCellular survival and cell death regulation
04

Disease associations

Cardiovascular disease (including heart failure, myocardial infarction)Ischemia-reperfusion injuryMetabolic cardiomyopathies
05

Safety considerations

Potential for metabolic inflexibility with chronic substrate modulationRisk of lipotoxicity with altered fatty acid metabolismMitochondrial dysfunctionOff-target systemic metabolic effects
06

Interacting drugs

Trimetazidine

6 more in the full profile.

07

Biomarkers

LactateKetone bodiesFatty acid metabolitesGlucose oxidation markers (e.g., PDH activity)Mitochondrial function indicators

Beyond the preview

Go deeper on Myocardial cell metabolism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myocardial cell metabolism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call